Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) has announced plans to release its financial results for the second quarter of 2024 on Thursday, August 8, 2024, before the financial markets open. The company will host a conference call at 8:00 a.m. ET on the same day to discuss the results and recent business highlights.

Investors and interested parties can access the call by dialing (800) 715-9871 (USA & Canada - Toll-Free) and entering Conference ID: 4155557. Additionally, a live webcast of the conference call will be available through the Investors section of Akebia's website at https://ir.akebia.com/. An online archive of the webcast will also be accessible via the same section of the company's website.

Akebia to Host Conference Call on August 8, 2024, at 8:00 a.m. ET

CAMBRIDGE, Mass., Aug. 2, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, prior to the open of financial markets.

Akebia will host a conference call on Thursday, August 8, 2024, at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call, please dial (800) 715-9871 (USA & Canada - Toll-Free) and enter Conference ID: 4155557.

A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-2024-financial-results-and-discuss-recent-business-highlights-302213120.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will Akebia Therapeutics (AKBA) report its Q2 2024 financial results?

Akebia Therapeutics (AKBA) will report its Q2 2024 financial results on Thursday, August 8, 2024, before the financial markets open.

What time is Akebia Therapeutics' (AKBA) Q2 2024 earnings conference call?

Akebia Therapeutics' (AKBA) Q2 2024 earnings conference call is scheduled for Thursday, August 8, 2024, at 8:00 a.m. ET.

How can investors access Akebia Therapeutics' (AKBA) Q2 2024 earnings call?

Investors can access Akebia Therapeutics' (AKBA) Q2 2024 earnings call by dialing (800) 715-9871 (USA & Canada - Toll-Free) and entering Conference ID: 4155557. A live webcast will also be available on the company's investor relations website.

Where can I find the webcast of Akebia Therapeutics' (AKBA) Q2 2024 earnings call?

The webcast of Akebia Therapeutics' (AKBA) Q2 2024 earnings call will be available through the Investors section of the company's website at https://ir.akebia.com/.